🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase I study to establish safety and feasibility of intravenously administ...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2014-06
Trial ID
NCT02159716
Treatments Being Tested
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Start Date
2015-10
Trial ID
NCT02580747
Treatments Being Tested
This Phase I/IIa clinical study is testing an experimental treatment called...
Status
Recruiting
Location
Hospital Clínic de Barcelona
Start Date
2026-02-04
Trial ID
NCT07471789
Treatments Being Tested
This phase I trial studies the side effects of pembrolizumab in treating pa...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-04-04
Trial ID
NCT02595866
This study will be a two-arm prospective 1:1 randomised controlled trial co...
Status
Completed
Location
Brighton and Sussex University Hospitals NHS Trust
Start Date
2015-11-27
Trial ID
NCT02336074
The purpose of this study is to evaluate the safety and efficacy of chimeri...
Status
Unknown
Location
Guangdong General Hospital
Start Date
2016-01
Trial ID
NCT02822326
Treatments Being Tested
This is a Phase 1, multicenter, open-label study o evaluate the safety and ...
Status
Unknown
Location
Hematology Department of the First Affiliated Hospital of Zhejiang University
Start Date
2021-03-12
Trial ID
NCT05346198
Treatments Being Tested
The goal of this clinical trial is to test the feasibility and safety of an...
Status
Recruiting
Location
Hospital Universitario La Paz
Start Date
2025-07-08
Trial ID
NCT06709469
Treatments Being Tested
This is an open-label phase 1 study to assess the safety and feasibility of...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2021-08-19
Trial ID
NCT04877613
Treatments Being Tested
The purpose of this study was to evaluate the safety and immunotherapeutic ...
Status
Terminated
Location
Alabama CRS
Start Date
2019-08-13
Trial ID
NCT03787095
Treatments Being Tested